Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Ferraro

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Journal of the Neurological Sciences|September 19, 2021
Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registryRachel Kenney, Mengling Liu, Sachi Patil, et al.
The Lancet. Neurology|March 22, 2020
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort studyAnna He, Bernd Merkel, James William L Brown, et al.
Multiple Sclerosis and Related Disorders|December 27, 2019
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorderAmy Kunchok, Charles Malpas, Petra Nytrova, et al.
JAMA|January 16, 2019
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple SclerosisJ William L Brown, Alasdair Coles, Dana Horakova, et al.
Neurology|October 7, 2020
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1aFrancesca Bovis, Tomas Kalincik, Fred Lublin, et al.
Brain : a Journal of Neurology|May 10, 2020
Early clinical markers of aggressive multiple sclerosisCharles B Malpas, Ali Manouchehrinia, Sifat Sharmin, et al.
European Journal of Neurology|December 11, 2020
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre studyMaria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MSTomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and DiscrepanciesSara Carta, Elia Sechi, Alessandro Dinoto, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Journal of the Neurological Sciences|September 19, 2021
Long-term outcomes in patients presenting with optic neuritis: Analyses of the MSBase registryRachel Kenney, Mengling Liu, Sachi Patil, et al.
The Lancet. Neurology|March 22, 2020
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort studyAnna He, Bernd Merkel, James William L Brown, et al.
Multiple Sclerosis and Related Disorders|December 27, 2019
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorderAmy Kunchok, Charles Malpas, Petra Nytrova, et al.
JAMA|January 16, 2019
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple SclerosisJ William L Brown, Alasdair Coles, Dana Horakova, et al.
Neurology|October 7, 2020
Treatment Response Score to Glatiramer Acetate or Interferon Beta-1aFrancesca Bovis, Tomas Kalincik, Fred Lublin, et al.
Brain : a Journal of Neurology|May 10, 2020
Early clinical markers of aggressive multiple sclerosisCharles B Malpas, Ali Manouchehrinia, Sifat Sharmin, et al.
European Journal of Neurology|December 11, 2020
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre studyMaria Di Gregorio, Valentina Liliana Adriana Torri Clerici, Giuseppe Fenu, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 4, 2022
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MSTomas Kalincik, Ilya Kister, Tamar E Bacon, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 19, 2025
Real-Life Evaluation of the MOGAD Diagnostic Criteria: Application Challenges and DiscrepanciesSara Carta, Elia Sechi, Alessandro Dinoto, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
Pageof 13